Cargando…
Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
BACKGROUND: Several prolonged typhoid fever epidemics have been reported since 2010 throughout eastern and southern Africa, including Malawi, caused by multidrug-resistant Salmonella Typhi. The World Health Organization recommends the use of typhoid conjugate vaccines (TCVs) in outbreak settings; ho...
Autores principales: | Phillips, Maile T., Antillon, Marina, Bilcke, Joke, Bar-Zeev, Naor, Limani, Fumbani, Debellut, Frédéric, Pecenka, Clint, Neuzil, Kathleen M., Gordon, Melita A., Thindwa, Deus, Paltiel, A. David, Yaesoubi, Reza, Pitzer, Virginia E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993384/ https://www.ncbi.nlm.nih.gov/pubmed/36890448 http://dx.doi.org/10.1186/s12879-023-08105-2 |
Ejemplares similares
-
Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries
por: Debellut, Frédéric, et al.
Publicado: (2019) -
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings
por: Antillón, Marina, et al.
Publicado: (2017) -
Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study
por: Limani, Fumbani, et al.
Publicado: (2022) -
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019) -
Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework
por: Debellut, Frédéric, et al.
Publicado: (2022)